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undergoing redo CABG from January 1998 through July 2014. The
effect of time on the prevalence of redo CABG cases and prior PCI,
and the preoperative patient’s characteristics on postoperative
early outcomes were analyzed. Patients were divided into two
groups based on the period of performance of redo CABG. Group 1:
January 1998 through December 2004 (n¼114) and group 2 : January
2005 through July 2014 (n¼ 95 ). RedoCABGwasperformedusingon-
pump technique in 159patients (group1:107pts andgroup2:52pts) ,
and off-technique in 50 patients (group 1 :7, group 2: 43 patients).
Results: Prevalence of redo CABG decreased from 4.6% in group 1
to 1.36% in group 2 (P¼ 0.000). Prevalence of PCI to redo CABG was
significantly increased from 10.5% in group 1 to 34.7% in group 2
(p¼ 0.000). ITA usage was more in group 1 than group 2 (71.9% vs
57.4%) (p¼ 0.033 ). The number of patients with advanced age, left
ventricular dysfunction and renal insufficiency had increased in
group 2. In hospital mortality did not change between the groups
(6 pts vs 2 pts : p¼ 0.236 ) but the incidence of post-operative low
cardiac output syndrome requiring IABP support has decreased 4
pts vs 2 pts : p¼ 0.691) in the later part of our study.
Conclusions: Surgical coronary revascularization has evolved
during the past one and half decades with redo CABG uncom-
monly performed in contemporary practice. Despite treating pa-
tients with more complex coronary artery disease and greater
medical co-morbidities, there is a significant reduction in opera-
tive morbidity and mortality.
The Intra/extracardiac Fenestrated Fontan
Procedure
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Background: The Fontan/Kreutzer operation for patients with a
functional single ventricle has undergone major technical modifi-
cations since its introduction in the early 1970’s. The latter modifi-
cation, the intra/extracardiac fenestrated Fontan procedure,
combines theadvantagesof the extracardiac conduit and the lateral
tunnel and has fewer disadvantages. Advantages of the intra/
extracardiac fenestrated Fontan include less risk of injury to the
crista terminals reducing the risk of atrial arrhythmias and easy
access for fenestration. The ring-supported conduit can be placed
working througha standardatrial incisionparallel to theAVgroove,
avoiding injury to the sinus node, the sinus node artery, and the
crista terminalis. A 4mmfenestration is punched in the short intra-
atrial segment of the conduit and suture attaches the atriotomy
incision to the margins of the conduit. An inverted T incision is
made at the bidirectional Glenn shunt anastomosis extending into
the right and left pulmonary artery as well as the superior vena
cava. The beveled superior end of the conduit is sutured to the
pulmonary arteries and cava using a continuous suture.
Methods and results: We report the anatomic and hemodynamic
outcomes in our first 11 patients undergoing the intra/extrac-
ardiac fenestrated Fontan procedure at our institute. Diagnosis
included double outlet right ventricle with or without other car-
diac anomalies, double inlet left ventricle, tricuspid atresia, and
hypoplastic left heart syndrome. Two patients had heterotaxy
syndrome. Mean age and weight at time of operation was 34.9
months and 12.8 kg, respectively. Mean cardiopulmonary bypass
time was 105 minutes and mean cross-clamp time was 58 mi-
nutes. End ventricular diastolic pressure (EDP) were similar pre-
and post-Fontan procedure, 10.6 mmHg and 10.7 mmHg respec-
tively. Mean atrial pressure was higher post-Fontan (8.1 mmHg
and 10.7 mmHg, respectively.) Mean pulmonary artery pressure
(MPAP) was higher post-Fontan (12.9 mmHg and 14.0 mmHg
respectively). Transpulmonary gradient (TPG) was less post-Fon-
tan procedure (4.8 mm Hg and 3.3 mmHg, respectively.) Chest
tubes were removed at a mean of 6.9 days. No patient had more
than mild AV valve regurgitation. Two patients had junctional
rhythm within the first 2 weeks after surgery, but only 1 had
junctional rhythm later than 2 weeks after surgery.
Pulmonary Endarterectomy for CTEPH
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Background: CTEPH is sequel of acute pulmonary embolism and
afflicts 1%-4% of the patients who have had a pulmonary embolic
episode. The disease is progressive and carries a dismal prognosis.
Methods: Eleven patients underwent Pulmonary endarterectomy
(PEA) for CTEPH. All patients underwent echocardiogram, right
heart catheterization and CT pulmonary angiography to confirm
the diagnosis and establish surgical candidacy.
Ten patients were in NYHA class III and one patient was NYHA
class II. The mean PA pressures ranged from 35 to 60mm of Hg,
PVR varied from 700 to 1600 dynes/-s-cm5.Five patients had Type I
disease and remaining had Type II disease.
All patients underwent bilateral pulmonary thromboendarter-
ectomy on CPB with two periods of deep hypothermic deep cir-
culatory arrest. All patients were electively ventilated overnight.
Results: There was no perioperative mortality The mean PA
pressures postoperatively varied from 25 to 35 mm of Hg and PVR
was below 500 in all patients. The patients after surgery are in
NYHA class I/II and significant improvement in their walk dis-
tance and Quality of life.
Conclusion: PEA offers good symptomatic relief to patients of
CTEPH and carries low morbidity and mortality in our experience.
Role of ambrisentan in the management of
pulmonary arterial hypertension in patients with
valvular heart disease undergoing cardiacsurgery
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Syed Javed Ali
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Background: Presence of severe pulmonary arterial hypertension
(PAH) in patients undergoing open valve replacement/repair sur-
gery is a marker of increased morbidity and mortality in the post
operative period. Endothelin antagonists have been shown to be
effective in reducing pulmonary pressures in a variety of cases.
However, their efficacy in secondary PAH is not well studied.
Methods: Patients undergoing valve surgery with pre-operative
severe PAH (peak PA systolic pressures >60 mm Hg) were given
ambrisentan 5mg once a day, starting a week before surgery and
continued post-operatively. Pulmonary Artery pressures and
indices of ventricular function were recorded pre-operatively, at
discharge and at 3rd month follow up and compared to similar
surgical patients not given ambrisentan in a single blinded
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fashion. Duration of hospital stay was also recorded for both the
groups. Patients with in-hospital mortality were excluded.
Results: The 2 groups (23 patients in the ambrisentan group and 21
in the control group) were matched in age, sex distribution and
baseline characteristics liketricuspid regurgitation (TR) grade, PA
pressures, RV tei index and left ventricular ejection fraction
(LVEF). Duration of hospital stay was significantly lower in the test
group. (Mean 6.1 vs 7.6 days, P¼0.004). At the time of discharge,
reduction in PAH (Mean change 9.39 v/s 11.52, p¼0.663) and RV tei
index (Meanchange 0.0017 v/s 0.0014, p¼0.989) were not signifi-
cantly different. However, at the end of 3 months, a significantly
greater reduction in PAH (Mean change 28.91 v/s 13.7, P¼0.003)
and improvement in RV function as measured by Tei index (Mean
change 0.038 v/s 0.007, P¼0.001) was found in the ambrisentan
group compared to the control group.
Conclusion: Ambrisentan seems to effectively reduce severe sec-
ondary PAH and hastens recovery of ventricular function in high
risk surgical patients undergoing valve replacement surgery in the
short term.
Cardio-Diabetes
Correlation of microalbuminuria with obesity and
cardiovascular risk markers in Type II diabetic
North Indian Punjabi population
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Background: Microalbuminuria has been identified as a predictor
of renal failure and an independent risk factor for cardiovascular
disease in patients with diabetes mellitus as well as in general
population. This study was aimed to determine the correlation of
microalbuminuria with obesity and cardiovascular risk markers.
Methods: 2044 Type II diabetes patients were enrolled in the study.
Microalbuminuria in all the subjects was estimated and the albu-
min to creatinine ratio (A:C) determined. Obesity parameters (BMI,
WHR), HbA1c, baPWV, Blood Pressure, ABI, LDL, HDL, and TGs of all
the subjects were also measured. baPWV was measured with VP-
2000/1000-Colin Corporation, (hyayashi komaki Japan). Micro-
albuminuria was measured Clinitek status Analyzer. (Bayer Health
Care).
Results: Overall prevalence ofmicroalbuminuria was 58.4% (54.6%
M/64.2%F). Microalbuminuria had a highly significant correlation
with duration of diabetes (p<0.001), HbA1c and BMI (p<0.05), Sys-
tolic and diastolic blood pressure (p<0.01). Positive correlationwas
found with PWV, ABI, Cholesterol, LDL & TG.
Conclusions: The high proportion of type 2 diabetes patients with
microalbuminuria raises implications for health policy in North
India. Screening programs and optimized control of modifiable
risk factors are needed to reduce the risk of diabetic nephropathy.
Early evaluation of coronary artery disease in
asymptomatic Type 2 Diabetes Mellitus patients
with TMT and CAG
N.C. Sarkar, S. Jain
SAIMS, Indore, India
Background: Type 2 Diabetes Mellitus is a major risk factor for
Coronary Artery Disease (CAD). Patients remain mostly asymp-
tomatic and thus diagnosed at an advance stage of the disease.
Our aim of study was to detect the coronary artery disease at an
early stage in asymptomatic patients.
Methods: 136 asymptomatic of Type 2 diabetes mellitus patients
were enrolled prospectively for TMT and subsequent coronary
angiography was performed on 96 (70.58%) TMT positive patients.
Diabetic status, clinical parameters including risk factors, TMT
and angiographic findings were analyzed.
Results: CAGwas performed in all TMT positive patients. CADwas
positive in 30 patients (45.45%) of high risk group (risk factors >2)
with multiple vessel involvement and 6 patients (20%) with single
vessel disease with low risk group (risk factors >1). Duration of
Diabetes Mellitus and multiple risk factors where correlated with
the severity as well as multiple coronary artery involvement.
Conclusions: A routine TMT of all long standing Type 2 diabetic
patients (duration > 10 years) and subsequent CAG should be done
for early detection of CAD to take early appropriate revasculari-
zation measure.
A cross sectional study to find the association
between prolonged QTC interval and
microalbuminuria in patients of type 2 diabetes
Bhise Shekhar Ramchandra
KLE University JN Med College, Belgaum, India
Background: The link between microalbuminuria and premature
death in type2diabetes isnot completelyexplainedbyconventional
cardiovascular risk factors. Cardiac autonomic neuropathy (CAN)
can be detected in at least one third of type 2 diabetic patients. CAN
is associated with a high mortality which is attributed not only to
sudden death but also to diabetic nephropathy. Prolonged QTc in-
terval is found to be a specific indicator for CAN. The present study
was undertaken to find the association between prolonged QTc in-
terval and microalbuminuria in type 2 diabetes patients.
Methods: The present one year cross-sectional study was con-
ducted on 86 (43 with normoalbuminuria and 43 with micro-
albuminuria) patients with type 2 DM during the period of January
2009 to December 2009. Urine albumin excretion test (Micro-
albumin to creatinine ratio) was done. Electrocardiogram was
done to calculate the QTc interval. QTc interval was calculated
using Bazzet’s formula.
Results: In the present study, 60.47% and 69.77% were males in
normoalbuminuric and microalbuminuric groups respectively.
Themean age in normoalbuminuric group was 54.51 ± 10.15 years
and it was 55.93 ± 11.73 years in microalbuminuric group. Most of
subjects had duration of diabetes less than 10 years (44.19% in
normoalbuminuric and 34.88% in microalbuminuric groups
respectively). QTc interval was significantly prolonged in 25.58%
of patients in normoalbuminuric and 69.77% in microalbuminuric
group (p ¼ 0.001). Mean QTc interval was significantly more
(454.73 ± 29.33 ms) in microalbuminuric group compared to nor-
moalbuminuric group (418.13 ± 27.44 ms) (p ¼ 0.001). Mean dura-
tion of diabetes was less (14.93 ± 3.81 years) in microalbuminuric
group compared to (16.00 ± 4.87 years) normoalbuminuric group.
Conclusions: The study showed that, prevalence of CAN as diag-
nosed by prolonged QTc interval was more in Type 2 DM patients
with microalbuminuria and type 2 diabetic patients with micro-
albuminuria can develop CAN with short duration of diabetes.
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